Elyse Seltzer
Overview
Elyse Seltzer received an average of $951K in total compensation, including $302K in salary, at Nabriva Therapeutics AG from 2015 to 2017.
Source: SEC filings on June 19, 2018 and August 18, 2017.
Related executives
We found eight more executives who work or worked at Nabriva Therapeutics AG.
Steven Gelone
Nabriva Therapeutics AG
Chief Operating Officer
Theodore Schroeder
Nabriva Therapeutics AG
Chief Executive Officer
Daniel Dolan
Nabriva Therapeutics AG
Chief Financial Officer
Jennifer Schranz
Nabriva Therapeutics AG
Chief Medical Officer
Colin Broom
Nabriva Therapeutics AG
Chief Executive Officer
Francesco Lavino
Nabriva Therapeutics AG
Chief Commercial Officer
Gary Sender
Nabriva Therapeutics AG
Chief Financial Officer
Peter Wolf
Nabriva Therapeutics AG